“Baseline Characteristics in Patients With Atopic Dermatitis from the North American Prospective Observational Study of Lebrikizumab (ADjoy)”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s734. Accessed April 29, 2026. https://skin.dermsquared.com/skin/article/view/4054.